Skip to main content

CRISPR/Cas9-compatible plasmids enabling seven dominant genetic selection methods for the human fungal pathogen Cryptococcus neoformans.

Boucher MJ, Madhani HD
Microbiol Spectr. 2025 Sep 25:e0193525. doi: 10.1128/spectrum.01935-25. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
241719pBHM2672Integration of DNA into Cryptococcus neoformans Safe Haven 1 locus, contains BLE marker for selection on phleomycin
241720pBHM2673Integration of DNA into Cryptococcus neoformans Safe Haven 1 locus, contains BSD marker for selection on blasticidin S
241722pBHM2675Integration of DNA into Cryptococcus neoformans Safe Haven 1 locus, contains ptxD marker for selection on media containing phosphite as a sole phosphorus source
241723pBHM2678Construction of fused marker-sgRNA inserts for Cryptococcus neoformans genome editing, contains BLE marker for selection on phleomycin
241724pBHM2679Construction of fused marker-sgRNA inserts for Cryptococcus neoformans genome editing, contains BSD marker for selection on blasticidin S
241725pBHM2680Construction of fused marker-sgRNA inserts for Cryptococcus neoformans genome editing, contains BSR marker for selection on blasticidin S
241726pBHM2681Construction of fused marker-sgRNA inserts for Cryptococcus neoformans genome editing, contains ptxD marker for selection on media containing phosphite as a sole phosphorus source
241727pBHM2674Integration of DNA into Cryptococcus neoformans Safe Haven 1 locus, contains BSR marker for selection on blasticidin S

Antibodies from Article